IFNG and neoplasm: Specifically, OMVs have been shown to drive a shift in the TME toward a pro-TH1 immune profile, characterized by the upregulation of key cytokines, such as CXCL10 and interferon-gamma (IFN-γ), which are associated with enhanced anti-tumor immunity (149).